Health Coaching for Heart Disease

(HEALTHCOACH Trial)

Overseen by Daniel Luger, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Rush University Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke? * Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes? * Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will: * Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6. * Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare * Keep a log of their blood pressure

Research Team

Daniel Luger, MD

Principal Investigator

Rush University Medical Center

Eligibility Criteria

This trial is for individuals who are food insecure and at risk of heart disease, high cholesterol, hypertension, or diabetes. It's designed to help those who need lifestyle changes to improve their health. Participants will be screened for cardiovascular issues and must commit to virtual health coaching sessions.

Inclusion Criteria

Patient is a participant at a CHI sponsored, community screening event

Patient provides informed consent and willingness to participate for the duration of the study

At least 1 cardiometabolic risk factor at suboptimal level: Systolic BP greater than 130mmHg and/or diastolic BP greater than 80mmHg, Obesity: BMI greater than 30 kg/m^2, Dyslipidemia: Total cholesterol greater than 200 mg/dL, Triglycerides greater than 150 mg/dL, LDL greater than 130 mg/dL, HDL less than 40 mg/dL in men or less than 50 mg/dL in women, Hemoglobin A1c greater than or equal to 5.7%, 10-year ASCVD score greater than 5%, Access to a telehealth compatible device

Exclusion Criteria

All cardiometabolic risk factors at optimal levels

No telehealth compatible device

Pregnant patients

Treatment Details

Interventions

• Longitudinal, Individualized Health Coaching (Behavioral Intervention)

Trial Overview The study tests if regular virtual health coaching can lower the risk of heart attack or stroke over ten years, reduce blood pressure, cholesterol levels, and manage diabetes in a population that lacks access to sufficient food.

Participant Groups

Group I: Intervention Experimental Treatment 1 Intervention

Patients will receive health coaching sessions, conducted by medical students and overseen by a licensed health coach, directed at individualized lifestyle modification relevant to the patient's cardiometabolic health profile. Patients will receive blood pressure cuffs and will be instructed as to how to measure and keep a log of their blood pressure to be reviewed during health coaching sessions. Sessions will occur biweekly for 1 month followed by the next 2 months. Sessions will last approximately 15 minutes in length. Objective data including blood pressure, point-of-care lipid panel and hemoglobin A1c, 10-year atherosclerotic cardiovascular disease (ASCVD) risk score, as well as surveys regarding depression, sleep apnea, physical activity, social determinants of health, and health literacy will be conducted at the time of study enrollment and at 3 and 6 months of study participation.

Who Is Running the Clinical Trial?

Rush University Medical Center

Lead Sponsor

Trials

448

Recruited

247,000+

The Physicians' Foundation

Collaborator